genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Cevec Pharmaceuticals
Bioprocessing
BioProcess International Showcases the Unsung Heroes of Drug Development
Bioprocessing
CEVEC and UCB Ink Gene Therapy Vector Deal
Bioprocessing
CEVEC Inks AAV Manufacturing Deal with Biogen
Industry News
CEVEC Licenses Cell Lines to NewLink Genetics
Insights
Novel Method for Glycoprotein Expression
Insights
Identifying & Isolating High-Producer Clones
News
Cevec Inks Another Cell-Line Licensing Agreement
Insights
Protein Production Prowess Progresses
Sponsored
Advertorial: CEVEC Pharmaceuticals
Bioprocessing
Cevec Raises $8.5M to Commercialize Human Cell-Expression Platform for Proteins and Vaccines
1
2
Page 1 of 2
Scroll Up
Scroll Up
